NSE:IPCALAB
Ipca Laboratories Limited · NSE · Healthcare · INR · FY for 2026
Figures on this page computed 2026-11-08 12:01 UTC
Last close
n/aINR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
43.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
21.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
11.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
5.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.10Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.19 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.64x
Its own average over 10 years, 58.66B.
- Profit1.78x
Its own average over 10 years, 6.41B.
- Free cash flow1.26x
Its own average over 10 years, 3.87B.
- Debt0.95x
Its own average over 10 years, 8.47B.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 1.78 times.
The filed years, as a table
10Each line is 100 at 2017-03-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-03-31 | 100.0 | 100.0 | 100.0 |
| 2018-03-31 | 104.1 | 123.1 | 100.0 |
| 2019-03-31 | 119.6 | 228.7 | 100.1 |
| 2020-03-31 | 147.3 | 311.7 | 100.2 |
| 2021-03-31 | 171.7 | 586.0 | 100.3 |
| 2022-03-31 | 184.7 | 454.4 | 100.5 |
| 2023-03-31 | 198.0 | 242.3 | 100.5 |
| 2024-03-31 | 244.2 | 281.4 | 100.5 |
| 2025-03-31 | 283.3 | 379.2 | 100.5 |
| 2026-03-31 | 305.6 | 586.6 | 100.5 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Figures behind the shape
Growth
12.2%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate12.2%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Five-year EPS growth rate-0.01%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
One-year change in net income54.7%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Returns on capital
21.2%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital21.2%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity14.2%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets9.2%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
64.1%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin64.1%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin24.2%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin11.8%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin5.0%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
43.2xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings43.2x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
Price to book6.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA25.2x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio5.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.10safer is higher, placed against 1,436 companies as of 2026-11-07
Debt to equity0.10
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio2.76
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage30.7x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
0.1%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield0.1%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Payout ratio4.6%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio9.3x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.